Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table.

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

Per WSJ’s forecasting data, the average UNH price target is $378.86 per share. Given that the current UNH price is $292.80 ...

Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to ...

Chairman, M&T Bank Corp., as Senior Executive VP & Head-Enterprise Platforms, and Manufacturers & Traders Trust Co., as EVP-Marketing, Consumer & Business Banking from 2018. Mr. Kay also formerly ...

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $225.85? Let's take a closer look at the ...

Healthcare has been running neck and neck with energy and consumer discretionary for the worst sector of 2025.

The stakes of Hinge Health's investors and executives are now worth millions after the company debuted on the stock market.

Shares of health insurance company Humana (NYSE:HUM) fell 6.5% in the afternoon session after the Centers for Medicare & ...

Bond yields inched higher and Wall Street flipped from small gains to losses before the opening bell Thursday after rising ...

Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to ...

Stocks are drifting on Wall Street Thursday following a rocky week so far because of worries coming out of the bond market ...